Elizabeth A. Barrett, Chief Executive Officer at UroGen Pharma Ltd. (URGN), bought 7,470 shares at $28.00 ($209K) on 2019-11-20, disclosed to the SEC on 2019-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| URGN | BUY | 2020-12-15 | $185K | — | Filing → |
| URGN | BUY | 2019-11-22 | $211K | — | Filing → |
| URGN | BUY | 2019-11-18 | $40K | — | Filing → |